Skip to main content
Addition of bortezomib to R-CHOP improves survival in DLBCL molecular subgroups
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Addition of bortezomib to R-CHOP improves survival in DLBCL molecular subgroups
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
1
Proteasome Inhibitor
0
0.9
Biologic Therapy
0
0.54
B-Cell Lymphoma
0
1
Lymphoma
0
0.26
Antineoplastic Drug
0
0.22
Cancer
0
0.13
Monoclonal Antibody
0
0.13
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.99
Edit Tags